Related Experiment Videos

Antithrombotic therapy in patients undergoing percutaneous coronary intervention

J J Popma¹, E M Ohman, J Weitz

¹Interventional Cardiology, Brigham and Women's Hospital, Boston, MA 02115, USA. jpopma@partners.org

|February 7, 2001

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.

Alimentary pharmacology & therapeutics·2018

Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease.

Journal of internal medicine·2010

Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.

Heart (British Cardiac Society)·2008

Clinical experience with abciximab during coronary revascularisation: an overview.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007

Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial.

Minerva cardioangiologica·2007

Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk.

Heart (British Cardiac Society)·2006

See all related articles